EyeNovi officials discuss approval of MydCombi ophthalmic spray for mydriasis
EyeNovi officials have shared their insights on the approval of MydCombi ophthalmic spray for mydriasis, which is the dilation of the pupil. The spray contains both tropicamide and phenylephrine, which are commonly used mydriatics, and is administered through a nozzle similar to that of a nasal spray. The approval was based on positive results from multiple clinical trials and offers a potential alternative to traditional eye drops for mydriasis. The officials expressed optimism about the convenience and precision of the spray, which they believe can enhance the patient experience and facilitate more accurate ophthalmic exams. This approval represents a significant milestone for EyeNovi as they continue to develop innovative ophthalmic treatments.